MGX·59102M104·US·equity·Healthcare - Biotechnology
MGX (METAGENOMI THERAPEUTICS INC) is held by 31 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($1.1M), TWO SIGMA INVESTMENTS, LP ($665,668), JACOBS LEVY EQUITY MANAGEMENT, INC ($512,085). Net institutional sentiment: Bearish.
See how MGX's score breaks down across 4 SEC sources
Showing 1-20 of 38
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer